Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1992
03/05/1992CA2072871A1 Preservation of blood, tissues and biological fluids
03/05/1992CA2072749A1 Antimicrobial preservation of plasma
03/05/1992CA2050424A1 2-tert-substituted methyloxapenem-3-carboxylic acids and esters, a process for their preparation and their use
03/04/1992EP0473268A2 Continuous release pharmaceutical compositions comprising a polypeptide covalently conjugated to a water soluble polymer
03/04/1992EP0473210A2 Recombinant Marek's disease virus
03/04/1992EP0473145A1 Compositions for inhibiting aminoglycoside nephrotoxicity
03/04/1992EP0472987A1 Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto
03/04/1992EP0472531A1 Proanthocyanidol-based composition and its pharmacological application.
03/04/1992CN1059149A Phospholipid derivatives of nucleosides, processes for prepn. thereof and use thereof as antiviral medicaments
03/03/1992WO1992003460A1 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof
03/03/1992US5093342 Use of omeprazole as an antimicrobial agent
03/03/1992US5093338 Lipophilic macrolide useful as an immunosuppressant
03/03/1992US5093324 Thiadiazole antiviral agents
03/03/1992US5093323 Antibiotic n-acetylbenanomicin b, and the production and uses thereof
03/03/1992US5093134 Tungstates
03/03/1992US5093117 Compositions and method for the treatment or prophylaxis of sepsis or septic shock
03/03/1992US5093116 Method of treating viral infection utilizing inteferon α and pipyridamole
03/03/1992CA1296726C 9-hydroxyalkoxyguanines
03/03/1992CA1296718C C.12 modified erythromycin a derivatives
03/03/1992CA1296717C Crystalline salts of [3s(z)]-2[[[1-(2-amino- 4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)- 3-azetidinyl]-amino]-2-oxoethylidene]-amino]oxy]acetic acid
03/03/1992CA1296669C Substance gif-2 and process for production of the same
03/03/1992CA1296630C Dual phase solvent carrier system
03/01/1992WO1992005760A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome
03/01/1992WO1992004457A1 Antibiotic ge1655 complex and its factors a, b and c
03/01/1992WO1992004046A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same
03/01/1992WO1992004034A1 Method for treating endotoxin shock using anti-adhesion antibodies
03/01/1992WO1992004016A1 Pharmaceutical composition of florfenicol
03/01/1992CA2090491A1 Antibiotic ge1655 complex and its factors a, b and c
03/01/1992CA2090470A1 Peptide antigens and immunoassays, test kits and vaccines using the same
03/01/1992CA2090464A1 Method for treating endotoxin shock using anti-adhesion antibodies
03/01/1992CA2089761A1 Method and compositions for diagnosing and treating chronic fatique immunodysfunction syndrome
03/01/1992CA2048309A1 Method and compositions for inhibiting aminoglycoside nephrotoxicity
02/1992
02/28/1992WO1992003473A1 Cd18 peptide medicaments for the treatment of disease
02/28/1992WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
02/28/1992WO1992003145A1 Method of treating viral infection
02/28/1992CA2090469A1 Ligand for the c-kit receptor and methods of use thereof
02/28/1992CA2090427A1 Cd18 peptide medicaments for the treatment of disease
02/28/1992CA2090401A1 Method of treating viral infection
02/27/1992DE4026265A1 Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel New phospholipid derivatives of nucleosides, their production and their use as antiviral drug
02/26/1992EP0472434A2 Antisense oligonucleotides complementary to the macromolecular synthesis operon of bacteria, and their uses in diagnosis and therapy
02/26/1992EP0472306A1 2-(9-fluorenonyl)-carbapenem antibacterial agents
02/26/1992EP0472078A2 Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses
02/26/1992EP0472077A2 Phosphonate containing hydroxyethylamin- and norstatin-type pseudopeptides
02/26/1992EP0472060A2 Antibiotic c-7 catechol-subtituted cephalosporin compounds, compositions, and use thereof
02/26/1992EP0472005A1 Antiviral antibiotic BU-4224V
02/26/1992EP0471991A2 1-Phenyl substituted 1H,3H-thiazolo[3,4-a]benzimidazoles, process for their preparation, and pharmaceutical compositions containing them
02/26/1992EP0471954A2 Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
02/26/1992EP0471872A1 Antifungal gel formulations
02/26/1992EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
02/26/1992EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus
02/26/1992EP0471683A1 Bis-(pyrrolidonyl alkylene) biguanides
02/26/1992CN1058959A Oligomers, their uses and formulations
02/26/1992CN1058958A Hiv-inhibiting benzeneacetamide derivatives
02/25/1992US5091576 Antipsoriasis, insecticides
02/25/1992US5091530 Bactericides
02/25/1992US5091523 Bactericides, antitumor agent
02/25/1992US5091522 Retinoic esters of d-desosamine, process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
02/25/1992US5091413 Antibiotic agent
02/25/1992US5091412 Novel antiviral terpene hydroquinones and methods of use
02/25/1992US5091411 Bactericides, antibiotics
02/25/1992US5091392 Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for their preparation and their use in medicaments
02/25/1992US5091389 Lipophilic macrolide useful as an immunosuppressant
02/25/1992US5091385 Destroys tumors or other biological contaminants infecting animals
02/25/1992US5091384 Anti-bacterial quinolone- and naphthyridone-carboxylic acid compounds
02/25/1992US5091383 Bactericides
02/25/1992US5091382 Cephalosporin derivatives
02/25/1992US5091371 Antifungal and antiviral antibiotic, benanomicin A 4"'-O-sulfate or its salt, and the production and uses thereof
02/25/1992US5091370 Angolamycin derivatives
02/25/1992US5091308 Process for the enzymatic dispersal of mycobacterium bovis - bcg
02/25/1992US5091181 Plant extract; used for preventing complete immune system dysfunction
02/25/1992CA2049645A1 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type
02/25/1992CA1296334C Substituted pyrimidoquinoxalines
02/25/1992CA1296330C Method of treating viral infections in humans and compositins therefor
02/25/1992CA1296329C Macrolide compounds
02/25/1992CA1296328C Macrolide compounds
02/25/1992CA1296252C Method and composition for prophylaxis and treatment of viral infections
02/24/1992WO1992003453A1 Antiviral agent
02/24/1992WO1992003158A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
02/24/1992CA2089888A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
02/24/1992CA2071915A1 Antiviral agent
02/24/1992CA2049497A1 Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses
02/24/1992CA2048832A1 Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
02/24/1992CA2046771A1 Antibiotic c-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and method of use thereof
02/24/1992CA2046442A1 Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and methods of use thereof
02/21/1992WO1992003462A1 New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs
02/20/1992WO1992002531A1 Novel polyamine conjugated oligonucleotides
02/20/1992WO1992002521A1 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
02/20/1992WO1992002484A1 Protein kinase c modulators with anti-inflammatory and antiviral activity
02/20/1992WO1992002242A1 Use of metalloporphyrins to potentiate aids therapy
02/20/1992WO1992002228A1 Viral (hiv) growth inhibition
02/20/1992WO1992002135A1 New synergistic composition of 2-(2-bromo-2-nitroethenyl) furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof
02/20/1992WO1991018599A3 1,4-dihydropyridines for application in combatting resistance to drugs
02/20/1992CA2088593A1 Use of metalloporphyrins to potentiate aids therapy
02/20/1992CA2087731A1 Novel polyamine conjugated oligonucleotides
02/19/1992EP0471407A2 New embodiments of the HIV principal neutralizing determinant
02/19/1992EP0471057A1 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections
02/19/1992EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these
02/19/1992CN1058781A Pyrano heterocyclic anthracycline analogs
02/18/1992WO1992003445A1 Novel cephalosporin compounds and processes for preparation thereof
02/18/1992US5089616 From 3-(2-amino-4-thiazolyl)-L-alanine, without protection of the aminothiazole group